ATAI Life Sciences AG — Form D/A
ATAI Life Sciences AG of MUNICH, 2M, a company, filed a Form D amendment with the SEC on 2020-10-20. The offering totals $33.4M, of which $10.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-10-20
- Form: D/A
- Accession: 0001776242-20-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $33.4M
- Amount sold: $10.9M
- Remaining: $22.5M
- Minimum investment: $110K
- Investors: 32
- Date of first sale: 2020-01-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-358759
Issuer
- Name: ATAI Life Sciences AG
- CIK: 0001776242
- Entity type: Corporation
- Jurisdiction: GERMANY
- Incorporated: 2018
- Address: BARER STR. 7, MUNICH, 2M, 80333
- Phone: 4917632963813
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Srinivas Rao | Promoter | San Mateo, CA |
| Christian Angermayer | Executive Officer | Mosta, O1 |
| Christian Angermayer | Promoter | Mosta, O1 |
| FLORIAN BRAND | Executive Officer | BERLIN, 2M |
| FLORIAN BRAND | Promoter | BERLIN, 2M |
| LARS WILDE | Promoter | BERLIN, 2M |
Other filings by this issuer (4)
More